Its not a Tricare benefit, but its an accessible and affordable alternative for Tricare beneficiaries who want GLP-1 treatment and cant get it covered through their plan
With solid growth in non-GLP-1 (+30%) and the expansion into Europe with the ZAVA acquisition, I don't see the long-term investment case hurt
We monitor your progress through regular virtual check-ins
Glucagon has its own effects on the digestive system, including influences on bile secretion, hepatic glucose output, and gut motility patterns that differ from GLP-1 effects
However, abnormal platelet activation and aggregation can lead to thrombosis, which is the underlying cause of many cardiovascular events such as myocardial infarction, ischemic stroke, and peripheral arterial disease